Medicinal Cannabis - Navigating the Maze
Medicinal cannabis has emerged as a therapeutic option for a range of clinical conditions, attracting interest from patients, healthcare professionals, and policymakers. Despite its growing use, clinicians often face barriers including regulatory complexity, variable product quality, limited clinical guidance, and concerns about safety and efficacy. This course aims to demystify medicinal cannabis, clarify clinical applications, regulatory frameworks, evidence‑based prescribing practices, and risk management strategies within a primary or specialist care setting. Participants will gain a thorough understanding of the pharmacology of cannabis and cannabinoids, therapeutic indications with supporting evidence, contraindications, dosing principles, adverse effect management, and legal‑ethical considerations. The course also explores emerging research, monitoring strategies, and patient communication techniques to support safe, informed care.
.jpg)
Learning Outcomes
What you'll learn
- Understand the pharmacology, cannabinoid profiles, and mechanisms of action of medicinal cannabis.
- Identify evidence‑based clinical indications and recognize where evidence is limited or inconclusive.
- Navigate regulatory and legal frameworks governing safe prescribing and access.
- Assess patient suitability, dosing strategies, and risk mitigation.
- Monitor effectiveness, side effects, drug interactions, and long‑term outcomes.
- Communicate effectively with patients about expectations, benefits, risks, and ethical considerations.
Stay updated with our


Learning Outcomes
What you'll learn
- Understand the pharmacology, cannabinoid profiles, and mechanisms of action of medicinal cannabis.
- Identify evidence‑based clinical indications and recognize where evidence is limited or inconclusive.
- Navigate regulatory and legal frameworks governing safe prescribing and access.
- Assess patient suitability, dosing strategies, and risk mitigation.
- Monitor effectiveness, side effects, drug interactions, and long‑term outcomes.
- Communicate effectively with patients about expectations, benefits, risks, and ethical considerations.
Stay updated with our


Training Overview
- Pharmacology of Cannabis and Cannabinoids
- Therapeutic Indications and Evidence Base
- Regulatory Frameworks and Safe Prescribing
- Patient Assessment and Individualized Treatment Planning
- Adverse Effects, Drug Interactions, and Risk Management
- Monitoring Outcomes, Follow‑Up, and Emerging Research
- Summary
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Top reviews
No reviews yet.
You May Also Like
Are you a qualified
Trainer or Instructor?
Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.
Refer a Friend &
Earn Rewards.
Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.
Frequently asked questions
Medicinal cannabis refers to cannabinoids and cannabis‑derived products used therapeutically under medical supervision.
THC is psychoactive and can alter cognition, while CBD is non‑intoxicating and modulates inflammation and neuromodulation.
Neuropathic pain, spasticity in multiple sclerosis, and chemotherapy‑induced nausea and vomiting have more established evidence.
Yes—especially drugs metabolized by cytochrome P450 pathways, requiring careful review and monitoring.
No—legal frameworks vary by country and region, affecting prescribing access, product availability, and restrictions.
Dizziness, sedation, dry mouth, altered cognition, anxiety, and potential long‑term risks like dependence.
.jpg)
.jpg)
.jpg)



